Brief: Senzime Q3 Adjusted Gross Margin 63%
06/11/2024 07:30
Nov 06 (Reuters) - Senzime Q3 EPS SEK -0.26. * Q3 sales SEK 17.406 million
Recent news on Senzime AB (publ)
See all newsBrief: Senzime Tetragraph System Receives Anvisa Approval For Sale In Brazil
Brief: Senzime Secures Contract With U.S. Hospital
Brief: Senzime Gets Additional FDA Class II 510(K) Clearance For Tetragraph System
Brief: Senzime's TetraGraph System Contracted On Three GPO Agreements In U.S.
Sweden's Senzime Q1 sales dip on weak US markets, strong krona